🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share comparison images, injection guides and assertions of next-day UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to users administering products of unknown origin.

Some experts said the popularity for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.

Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or prison.

Service Response and Material Removal

According to TikTok, the service has removed problematic material and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform safe and investing in enhancing compliance measures.

Digital Marketplace Operations

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at residence.

Within moments of entering one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or past usage.

Item Details and Pricing

Inside these communities, posts show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram stated it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting materials they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has previously encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to possibly serious health risks”.